Correlation Between Monte Rosa and AC Immune
Can any of the company-specific risk be diversified away by investing in both Monte Rosa and AC Immune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monte Rosa and AC Immune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monte Rosa Therapeutics and AC Immune, you can compare the effects of market volatilities on Monte Rosa and AC Immune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monte Rosa with a short position of AC Immune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monte Rosa and AC Immune.
Diversification Opportunities for Monte Rosa and AC Immune
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Monte and ACIU is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Monte Rosa Therapeutics and AC Immune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AC Immune and Monte Rosa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monte Rosa Therapeutics are associated (or correlated) with AC Immune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AC Immune has no effect on the direction of Monte Rosa i.e., Monte Rosa and AC Immune go up and down completely randomly.
Pair Corralation between Monte Rosa and AC Immune
Given the investment horizon of 90 days Monte Rosa Therapeutics is expected to generate 3.5 times more return on investment than AC Immune. However, Monte Rosa is 3.5 times more volatile than AC Immune. It trades about 0.08 of its potential returns per unit of risk. AC Immune is currently generating about 0.04 per unit of risk. If you would invest 639.00 in Monte Rosa Therapeutics on August 29, 2024 and sell it today you would earn a total of 221.00 from holding Monte Rosa Therapeutics or generate 34.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monte Rosa Therapeutics vs. AC Immune
Performance |
| Timeline |
| Monte Rosa Therapeutics |
| AC Immune |
Monte Rosa and AC Immune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monte Rosa and AC Immune
The main advantage of trading using opposite Monte Rosa and AC Immune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monte Rosa position performs unexpectedly, AC Immune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will offset losses from the drop in AC Immune's long position.| Monte Rosa vs. Valneva SE ADR | Monte Rosa vs. Bright Minds Biosciences | Monte Rosa vs. HP Inc | Monte Rosa vs. Intel |
| AC Immune vs. Pmv Pharmaceuticals | AC Immune vs. Eliem Therapeutics | AC Immune vs. MediciNova | AC Immune vs. Pharvaris BV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |